Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
| Image |  |
|---|---|
| Description | scientific article published on 5 October 2015 |
| Author/s |
author: Kathleen Ryan Peter Revill Ashley Mansell Tali Lang Sang Hoon Ahn Kumar Visvanathan |
| Publication date | October 5, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |